Correlation Between Absci Corp and InMed Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Absci Corp and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Absci Corp and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Absci Corp and InMed Pharmaceuticals, you can compare the effects of market volatilities on Absci Corp and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Absci Corp with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Absci Corp and InMed Pharmaceuticals.

Diversification Opportunities for Absci Corp and InMed Pharmaceuticals

0.36

Correlation Coefficient

Absci Corp  InMed Pharmaceuticals

Weak diversification

The 3 months correlation between Absci and InMed is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Absci Corp and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and Absci Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Absci Corp are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of Absci Corp i.e., Absci Corp and InMed Pharmaceuticals go up and down completely randomly.

Pair Corralation between Absci Corp and InMed Pharmaceuticals

Given the investment horizon of 90 days Absci Corp is expected to generate 0.53 times more return on investment than InMed Pharmaceuticals. However, Absci Corp is 1.9 times less risky than InMed Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. InMed Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest  200.00  in Absci Corp on September 16, 2024 and sell it today you would earn a total of  170.00  from holding Absci Corp or generate 85.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Absci Corp  vs.  InMed Pharmaceuticals

Absci Corp

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Absci Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Absci Corp may actually be approaching a critical reversion point that can send shares even higher in January 2025.

InMed Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in InMed Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, InMed Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Absci Corp and InMed Pharmaceuticals

The main advantage of trading using opposite Absci Corp and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Absci Corp position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.

The idea behind Absci Corp and InMed Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.